Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-002654-36Phase 4Active
Phase 4, randomised, open-label trial in migraine, migraine with aura and migraine without aura comparing Zolmitriptan nasal spray 5 mg with Sumatriptan RDT 100 mg (2 arms). Started Aug 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-002654-36.